Holen Sie sich die Stockscreener-App
4.035
2.92%
0.115
Schlusskurs vom Vortag:
$3.92
Offen:
$3.9
24-Stunden-Volumen:
502.57K
Relative Volume:
0.63
Marktkapitalisierung:
$502.14M
Einnahmen:
$193.01M
Nettoeinkommen (Verlust:
$-12.15M
KGV:
-44.83
EPS:
-0.09
Netto-Cashflow:
$454.00K
1W Leistung:
-1.11%
1M Leistung:
-10.14%
6M Leistung:
-23.00%
1J Leistung:
-38.12%
1-Tages-Spanne:
$3.88
$4.10
1-Wochen-Bereich:
$3.88
$4.16
52-Wochen-Spanne:
$3.88
$7.63
Cytek Biosciences Inc Stock (CTKB) Company Profile
Firmenname
Cytek Biosciences Inc
Sektor
Branche
Telefon
(877) 922-9835
Adresse
47215 LAKEVIEW BOULEVARD, FREMONT
Vergleichen Sie CTKB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
4.035 | 502.14M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
131.82 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.75 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
374.98 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.73 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.16 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-31 | Herabstufung | Goldman | Buy → Sell |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-07-19 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
Cytek Biosciences Inc Aktie (CTKB) Neueste Nachrichten
Cell Analyzer | Cytek Biosciences Inc. | Products - Photonics Spectra
106,597 Shares in Cytek Biosciences, Inc. (NASDAQ:CTKB) Purchased by Teacher Retirement System of Texas - Defense World
Proficio Capital Partners LLC Invests $71,000 in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences stock hits 52-week low at $3.99 amid market shifts - Investing.com
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Purchased by PNC Financial Services Group Inc. - Defense World
Cytek Biosciences expands cell analysis offerings with the affordable, user-friendly Cytek Muse Micro System - SelectScience
Charles Schwab Investment Management Inc. Increases Stock Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences (NASDAQ:CTKB) Trading Up 2.2% – What’s Next? - Defense World
Stephens Reiterates “Overweight” Rating for Cytek Biosciences (NASDAQ:CTKB) - Defense World
Cytek Biosciences stock hits 52-week low at $4.05 - Investing.com India
Cytek Biosciences stock hits 52-week low at $4.05 By Investing.com - Investing.com UK
Cytek Biosciences Launches Next-Generation Muse Micro Cell Analyzer to Transform Flow Cytometry Accessibility - Nasdaq
Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System - GlobeNewswire
Revolutionary Budget-Friendly Cell Analyzer Transforms Biotech Research Accessibility - StockTitan
Bank of New York Mellon Corp Grows Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Proficio Capital Partners LLC Takes Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences stock hits 52-week low at $4.19 amid market challenges - Investing.com Australia
Cytek Biosciences stock hits 52-week low at $4.19 amid market challenges By Investing.com - Investing.com South Africa
Cytek Biosciences (CTKB) to Release Earnings on Wednesday - The AM Reporter
Cytek Biosciences, Inc. (CTKB): Why Are Hedge Funds Bullish On This Cash-Rich Penny Stock? - Insider Monkey
12 Cash-Rich Penny Stocks To Buy According To Hedge Funds - Insider Monkey
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q4 2024 Earnings Call Transcript - MSN
Cytek Biosciences (CTKB) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by Principal Financial Group Inc. - Defense World
Cytek Biosciences (NASDAQ:CTKB) Price Target Cut to $8.00 by Analysts at Piper Sandler - Defense World
Cytek Biosciences Reports Mixed Earnings Amid Growth and Challenges - TipRanks
Cytek Biosciences (NASDAQ:CTKB) Hits New 1-Year Low – Here’s Why - Defense World
Cytek Biosciences stock hits 52-week low at $4.6 amid market challenges - Investing.com Australia
Is There An Opportunity With Cytek Biosciences, Inc.'s (NASDAQ:CTKB) 22% Undervaluation? - Yahoo Finance
Cytek Biosciences (NASDAQ:CTKB) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
Cytek Biosciences stock hits 52-week low at $4.6 amid market challenges By Investing.com - Investing.com South Africa
Cytek Biosciences, Inc. SEC 10-K Report - TradingView
Cytek Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Cytek Biosciences Reports Growth and Strategic Expansion - TipRanks
Cytek Biosciences earnings beat by $0.01, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: Cytek Biosciences Q4 2024 results miss forecasts By Investing.com - Investing.com South Africa
Cytek Biosciences, Inc. (CTKB) Tops Q4 Earnings Estimates - Yahoo Finance
Earnings call transcript: Cytek Biosciences Q4 2024 results miss forecasts - Investing.com
Cytek Biosciences reports Q4 revenue $57.48M, consensus $59.38M - TipRanks
Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook - GlobeNewswire
Cytek's Earnings Show Profitability Surge: Net Loss Halved While Revenue Climbs Just 4% - StockTitan
Cytek Biosciences (CTKB) to Release Quarterly Earnings on Thursday - MarketBeat
(CTKB) Proactive Strategies - Stock Traders Daily
Cytek Biosciences, Inc. (NASDAQ:CTKB) Short Interest Update - MarketBeat
Cytek Biosciences (CTKB) Projected to Post Quarterly Earnings on Thursday - Defense World
Cytek Biosciences (NASDAQ:CTKB) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Finanzdaten der Cytek Biosciences Inc-Aktie (CTKB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cytek Biosciences Inc-Aktie (CTKB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Yan Ming | CHIEF TECHNOLOGY OFFICER |
Apr 09 '24 |
Sale |
7.00 |
1,900 |
13,304 |
6,008,502 |
0.80%
1.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):